|
|||||
       |
Kendall Square skyline, Cambridge, Massachusetts (Shinkuken, WikiMedia Commons) 6 May 2015. Pharmaceutical maker Eli Lilly and Company is opening a new research facility in Cambridge, Massachusetts concentrating on drug delivery and medical devices. The research center, in Cambridge’s Kendall Square, is expected to open by the end of 2015 and hire some 30 . . . → Read More: Eli Lilly Opening Drug Delivery, Device Research Center  Comments are closed  Hiring/layoffs  biomedical, engineering, life sciences, medical device, pharmaceuticals Video: Centimeter-level GPS used in a virtual reality headset (University of Texas, Austin) 6 May 2015. An engineering lab at University of Texas in Austin designed a low-cost portable global positioning system with precision to a few centimeters, and started a company to take the technology to market. A team from UT-Austin’s . . . → Read More: New Company Founded to Develop Centimeter-Accurate GPS One comment - (Comments are closed) New products computer science, engineering, entrepreneurs, mathematics, physical sciences, software, space, university Anne Wojcicki (23andMe) 5 May 2015. The personal genetics company 23 andMe and Lupus Research Institute are collaborating on a study of genetic associations with systemic lupus erythematosus, the disease more commonly known as lupus. Financial and intellectual property details of the collaboration between 23andMe, Lupus Research Institute, and Pfizer Inc. serving as . . . → Read More: 23andMe, Lupus Institute Partner on Genetics Study 2 comments - (Comments are closed) Joint ventures/collaborations biomedical, genomics, life sciences, statistics Liver biopsy from patient with alpha-1 antitrypsin deficiency (Jerard Gardner, WikiMedia Commons) 5 May 2015. An early-stage clinical trial is testing a therapy derived from genetic material to treat alpha-1 antitrypsin deficiency, a rare inherited disease affecting the liver and lungs. The therapy, code-named ARC-AAT, is developed by Arrowhead Research Corporation, a biopharmaceutical . . . → Read More: Trial Underway Testing RNA Therapy for Rare Liver Disorder Comments are closed Regulations biomedical, biotechnology, clinical trials, genomics, life sciences, nanotechnology, pharmaceuticals Kate Rittenhouse-Olson (Douglas Levere, University at Buffalo) 4 May 2015. A three year-old company started by a University at Buffalo microbiologist received a $2 million grant to develop an antibody into a clinical treatment for breast and other types of cancer. For-Robin in Williamsville, New York, received the two-year award from National Cancer . . . → Read More: Cancer Therapy Spin-Off Gets $2M Small Business Grant One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, entrepreneurs, grant, life sciences, NIH, patent, pharmaceuticals, preclinical, university Human embryonic stem cell colony (National Institute of General Medical Sciences, NIH) 4 May 2015. Tests with lab rats of a therapy for degenerating retinas in the eyes, show the treatments derived from human embryonic stem cells can restore visual functions. Results of the treatments, developed by Cell Cure Neurosciences Ltd., are scheduled . . . → Read More: Stem Cells Treat Vision Disorders in Animal Tests Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, Israel, life sciences, pharmaceuticals, stem cells, university (NASA.gov) 1 May 2015. MyoKardia Inc., a developer of therapies for inherited heart diseases, raised $46 million in its second venture funding round. Taking part in the financing for the South San Francisco, California company are the drug company Sanofi that already holds an equity stake in MyoKardia, as well as venture capital . . . → Read More: Heart Drug Developer Raises $46M in Venture Funds Comments are closed Finance biomedical, clinical trials, equity, genomics, heart disease, investment, life sciences, pharmaceuticals, venture capital Ashish Deshpande (University of Texas, Austin) 1 May 2015. A robotic device that helps recover upper-body functions for people with neurological or spinal injuries is being developed by engineers at University of Texas in Austin. Developers of the exoskeleton, called Harmony, plan clinical trials of the device later in 2015. Harmony is a project . . . → Read More: Robotic Exoskeleton Developed for Upper-Body Rehab Comments are closed New products biomedical, clinical trials, engineering, medical device, robotics, software, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.